Cargando…
ABCC1, ABCG2 and FOXP3: Predictive Biomarkers of Toxicity from Methotrexate Treatment in Patients Diagnosed with Moderate-to-Severe Psoriasis
Background: Methotrexate (MTX) is one of the most extensively used drugs in the treatment of moderate-to-severe psoriasis (PS). However, it frequently must be suspended owing to the toxicity in certain patients. Objective: To evaluate the influence of ABCC1, ABCG2, and FOXP3 in the development of MT...
Autores principales: | Membrive-Jiménez, Cristina, Vieira-Maroun, Sayleth, Márquez-Pete, Noelia, Cura, Yasmin, Pérez-Ramírez, Cristina, Tercedor-Sánchez, Jesús, Jiménez-Morales, Alberto, Ramírez-Tortosa, María del Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526923/ https://www.ncbi.nlm.nih.gov/pubmed/37761008 http://dx.doi.org/10.3390/biomedicines11092567 |
Ejemplares similares
-
Influence of Genetic Polymorphisms on Response to Biologics in Moderate-to-Severe Psoriasis
por: Membrive Jiménez, Cristina, et al.
Publicado: (2021) -
Clinical Application of Pharmacogenetic Markers in the Treatment of Dermatologic Pathologies
por: Membrive Jiménez, Cristina, et al.
Publicado: (2021) -
Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe Psoriasis
por: Membrive-Jiménez, Cristina, et al.
Publicado: (2023) -
Single Nucleotide Polymorphisms in the Vitamin D Metabolic Pathway and Their Relationship with High Blood Pressure Risk
por: Rojo-Tolosa, Susana, et al.
Publicado: (2023) -
Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients
por: Cura, Yasmin, et al.
Publicado: (2023)